Mosaic ImmunoEngineering (CPMV) Receivables (2011 - 2014)
Mosaic ImmunoEngineering (CPMV) posted quarterly Receivables of $80745.0 for Q1 2014, up 292.54% year-over-year from $20570.0 in Q1 2013, and up 16.15% quarter-over-quarter from $69519.0 in Q4 2013.
Mosaic ImmunoEngineering (CPMV) Receivables (2011 - 2014) Analysis & Trends
Mosaic ImmunoEngineering's Receivables history runs 4 years deep, the most recent figure standing at $80745.0 for Q1 2014.
- In Q1 2014, Receivables rose 292.54% year-over-year to $80745.0; the TTM figure through Feb 2014 stood at $80745.0 (up 292.54% YoY), while the FY2013 annual figure was $16538.0, changed N/A from the prior year.
- Receivables for Q1 2014 stood at $80745.0, up from $69519.0 in the prior quarter.
- The five-year high for Receivables was $316810.0 in Q2 2011, with the low at $7012.0 in Q4 2012.
- The 4-year median for Receivables is $69519.0 (2013), against an average of $101456.0.
- The sharpest annual moves came in 2012 and 2013: Receivables sank 93.84% in 2012, then soared 891.43% in 2013.
- Mosaic ImmunoEngineering's Receivables stood at $113786.0 in 2011, then tumbled by 93.84% to $7012.0 in 2012, then jumped by 891.43% to $69519.0 in 2013, then advanced by 16.15% to $80745.0 in 2014.
- Business Quant data shows CPMV's Receivables at $80745.0 in Q1 2014, $69519.0 in Q4 2013, and $33400.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2014 | 80,745.00 |
| Nov 30, 2013 | 69,519.00 |
| Aug 31, 2013 | 33,400.00 |
| May 31, 2013 | 16,538.00 |
| Feb 28, 2013 | 20,570.00 |
| Nov 30, 2012 | 7,012.00 |
| Nov 30, 2011 | 113,786.00 |
| Aug 31, 2011 | 254,724.00 |
| May 31, 2011 | 316,810.00 |